Life Sciences 4.0: Securing value through data-driven platforms

Life sciences companies at risk of falling behind technology competitors in race to address evolving consumer demands

  • New EY report looks at effect of consumerism and affordability on the life sciences industry 
  • More than 75% of life sciences Fortune 500 companies may fall out of ranking by 2023, due to increasing competition and industry convergence
  • The ability to unlock the power of data by connecting, combining and sharing it will be essential for future value creation

Access the full report here.

Comments are closed.